SCHEMBL13019656

SCHEMBL13019656

CCc1cccc(I)c1I

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRA1 P14867 4/20 0.48
GABRB2 P47870 4/20 0.48
TAAR1 Q96RJ0 2/20 0.38
IDO1 P14902 2/20 0.37
HTR1A P08908 1/20 0.36
DAO P14920 1/20 0.35
MGLL Q99685 1/20 0.34
PDK2 Q15119 1/20 0.34
PIM1 P11309 1/20 0.34
PIM3 Q86V86 1/20 0.34
ALDH1A1 P00352 1/20 0.33
LMNA P02545 1/20 0.33
HTT P42858 1/20 0.33
CYP1A2 P05177 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
KCNH2 Q12809 1/20 0.33
SCN5A Q14524 1/20 0.33
TTR P02766 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7571313 0.87 GABRA1 (0.55) GABRA1GABRB2TAAR1HTR1ADAO
SCHEMBL13019660 0.82 GABRA1 (0.39) GABRA1GABRB2PDK2
SCHEMBL172963 0.79
SCHEMBL1517219 0.78 GABRA1 (0.46) GABRA1GABRB2TAAR1ALDH1A1HTT
SCHEMBL20542550 0.78 GABRA1 (0.46) GABRA1GABRB2TAAR1IDO1HTR1A
SCHEMBL30029990 0.78 GABRA1 (0.46) GABRA1GABRB2TAAR1ALDH1A1HTT
SCHEMBL19085450 0.78 GABRA1 (0.46) GABRA1GABRB2TAAR1IDO1HTR1A
SCHEMBL8346814 0.78 GABRA1 (0.46) GABRA1GABRB2TAAR1IDO1HTR1A
SCHEMBL21286977 0.78 LIPG (0.40) TAAR1CYP2D6CYP2C9KCNH2
SCHEMBL12086036 0.77 TAAR1 (0.50) GABRA1GABRB2TAAR1IDO1MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210104682-A1 ORGANIC LIGHT-EMITTING DEVICE AND DEVICE INCLUDING SAME SAMSUNG DISPLAY CO., LTD. (KR) 2021-04-08 US disclosed
CN-110002930-A A kind of method of hydrogenating reduction alkenyl aroma halo derivatives 浙江大学 2019-07-12 CN disclosed
WO-2017035349-A1 AMIDE COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS ACHILLION PHARMACEUTICALS, INC. (US) 2017-03-02 WO disclosed
US-20100316567-A1 ETHER AND ALKYL PHOSPHOLIPID COMPOUNDS FOR TREATING CANCER AND IMAGING AND DETECTION OF CANCER STEM CELLS CELL ACQUISITION CORP. 2010-12-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100316567-A1 ETHER AND ALKYL PHOSPHOLIPID COMPOUNDS FOR TREATING CANCER AND IMAGING AND DETECTION OF CANCER STEM CELLS PHOSPHO1, PEBP1, SGMS1 GABRA1 3675/4885GABRB2 4153/4885TAAR1 1274/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.